Showing results (241-250 of 285) with videos related to
Sort By:
Pageof 29
Oncotarget|September 1, 2016
PEITC-mediated inhibition of mRNA translation is associated with both inhibition of mTORC1 and increased eIF2α phosphorylation in established cell lines and primary human leukemia cellsAlison Yeomans, Elizabeth Lemm, Sarah Wilmore, et al.Journal of Medicinal Chemistry|March 14, 2014
Discovery and development of hepatitis C virus NS5A replication complex inhibitorsMakonen Belema, Omar D Lopez, John A Bender, et al.Journal of Virology|October 9, 2009
Identification of hepatitis C virus NS5A inhibitorsJulie A Lemm, Donald O'Boyle, Mengping Liu, et al.The Journal of General Virology|July 29, 2011
The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localizationDike Qiu, Julie A Lemm, Donald R O'Boyle, et al.GMS Hygiene and Infection Control|February 13, 2020
Air quality in the operating room: Surgical site infections, HVAC systems and discipline - position paper of the German Society of Hospital Hygiene (DGKH)Walter Popp, Christof Alefelder, Sonja Bauer, et al.Cell|July 10, 2012
Follicular dendritic cells emerge from ubiquitous perivascular precursorsNike Julia Krautler, Veronika Kana, Jan Kranich, et al.The Journal of Infectious Diseases|June 27, 2022
Wearable Sensor-Based Detection of Influenza in Presymptomatic and Asymptomatic IndividualsDorota S Temple, Meghan Hegarty-Craver, Robert D Furberg, et al.Virology|July 31, 2013
Characterizations of HCV NS5A replication complex inhibitorsDonald R O'Boyle Ii, Jin-Hua Sun, Peter T Nower, et al.Antimicrobial Agents and Chemotherapy|May 18, 2011
Discovery of potent hepatitis C virus NS5A inhibitors with dimeric structuresJulie A Lemm, John E Leet, Donald R O'Boyle, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical StilbenesJeffrey L Romine, Denis R St Laurent, John E Leet, et al.Pageof 29